Cargando…
Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB)
Synthetic Cannabinoids (SCB) are engineered chemical compounds that share a similar chemical structure with the active ingredient of marijuana, delta-9-tetrahydrocanabinol. Although the FDA has not approved the use of SCB without a prescription from a licensed health-care provider, the cost effectiv...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427457/ https://www.ncbi.nlm.nih.gov/pubmed/32850099 http://dx.doi.org/10.1080/20009666.2020.1781349 |
_version_ | 1783570881294893056 |
---|---|
author | Parajuli, Priyanka Regmi, Manjari Rani Lara-Garcia, Odalys Estefania Abu Limon, Ismael Deckard, Alan |
author_facet | Parajuli, Priyanka Regmi, Manjari Rani Lara-Garcia, Odalys Estefania Abu Limon, Ismael Deckard, Alan |
author_sort | Parajuli, Priyanka |
collection | PubMed |
description | Synthetic Cannabinoids (SCB) are engineered chemical compounds that share a similar chemical structure with the active ingredient of marijuana, delta-9-tetrahydrocanabinol. Although the FDA has not approved the use of SCB without a prescription from a licensed health-care provider, the cost effectiveness and availability of SCB has made it a popular choice among recreational drug users. Manufacture of SCB as a street drug is not regulated. These SCB are highly potent chemicals that cause various severe toxicities. In this case report, we describe an adult who suffered from PRES after consuming K2, a synthetic cannabinoid. |
format | Online Article Text |
id | pubmed-7427457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-74274572020-08-25 Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB) Parajuli, Priyanka Regmi, Manjari Rani Lara-Garcia, Odalys Estefania Abu Limon, Ismael Deckard, Alan J Community Hosp Intern Med Perspect Case Report Synthetic Cannabinoids (SCB) are engineered chemical compounds that share a similar chemical structure with the active ingredient of marijuana, delta-9-tetrahydrocanabinol. Although the FDA has not approved the use of SCB without a prescription from a licensed health-care provider, the cost effectiveness and availability of SCB has made it a popular choice among recreational drug users. Manufacture of SCB as a street drug is not regulated. These SCB are highly potent chemicals that cause various severe toxicities. In this case report, we describe an adult who suffered from PRES after consuming K2, a synthetic cannabinoid. Taylor & Francis 2020-08-02 /pmc/articles/PMC7427457/ /pubmed/32850099 http://dx.doi.org/10.1080/20009666.2020.1781349 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Parajuli, Priyanka Regmi, Manjari Rani Lara-Garcia, Odalys Estefania Abu Limon, Ismael Deckard, Alan Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB) |
title | Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB) |
title_full | Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB) |
title_fullStr | Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB) |
title_full_unstemmed | Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB) |
title_short | Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB) |
title_sort | man vs. man-made marijuana: a case of drug-induced posterior reversible encephalopathy syndrome (pres) due to k2, a ynthetic cannabinoid (scb) |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427457/ https://www.ncbi.nlm.nih.gov/pubmed/32850099 http://dx.doi.org/10.1080/20009666.2020.1781349 |
work_keys_str_mv | AT parajulipriyanka manvsmanmademarijuanaacaseofdruginducedposteriorreversibleencephalopathysyndromepresduetok2ayntheticcannabinoidscb AT regmimanjarirani manvsmanmademarijuanaacaseofdruginducedposteriorreversibleencephalopathysyndromepresduetok2ayntheticcannabinoidscb AT laragarciaodalysestefania manvsmanmademarijuanaacaseofdruginducedposteriorreversibleencephalopathysyndromepresduetok2ayntheticcannabinoidscb AT abulimonismael manvsmanmademarijuanaacaseofdruginducedposteriorreversibleencephalopathysyndromepresduetok2ayntheticcannabinoidscb AT deckardalan manvsmanmademarijuanaacaseofdruginducedposteriorreversibleencephalopathysyndromepresduetok2ayntheticcannabinoidscb |